G. Prager

机构：Universitätszahnklinik Wien, Medical University of Vienna

发表论文 15 篇 · 总被引 159 次 · h-index 5

代表论文

First-line and second-line treatment of patients with metastatic pancreatic adenocarcinoma in routine clinical practice across Europe: a retrospective, observational chart review study (2020 · ESMO Open · 被引 65)
Selpercatinib in RET fusion-positive non-small-cell lung cancer (SIREN): a retrospective analysis of patients treated through an access program (2021 · Therapeutic Advances in Medical Oncology · 被引 44)
Phase III FIRE-4 study (AIO KRK-0114): Influence of baseline liquid biopsy results in first-line treatment efficacy of FOLFIRI/cetuximab in patients with tissue RAS-WT mCRC. (2023 · Journal of Clinical Oncology · 被引 21)
FIRE-4 (AIO KRK-0114): Randomized study evaluating the efficacy of cetuximab re-challenge in patients with metastatic RAS wild-type colorectal cancer responding to first-line treatment with FOLFIRI plus cetuximab. (2025 · Journal of Clinical Oncology · 被引 9)
Chart Review of Diagnostic Methods, Baseline Characteristics and Symptoms for European Patients with Pancreatic Cancer (2021 · Future Oncology · 被引 9)
384TiP Quemliclustat and chemotherapy in previously untreated patients with metastatic pancreatic ductal adenocarcinoma: PRISM-1, a randomized, placebo-controlled, phase III trial (2025 · Annals of Oncology · 被引 3)